BAY987521

PreclinicalSmall molecule

Bayer

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

IrritationCompleted

IrritationPreclinical

Completed

Clinical

Trials by Indication[1]

Irritation1 trial

Evaluation of the Irritation Potential of Sunscreen Products in Human Eyes

Completed· Bayer logo

Bayer·N/A·NCT02854137·23 enrolled

Unspecified11 trials

Sun Protection Factor Assay (317/2016)

Completed· Bayer logo

Bayer·N/A·NCT02995018·11 enrolled

18475 - Sun Protection Factor Assay

Completed· Bayer logo

Bayer·N/A·NCT02774252·13 enrolled

Sun Protection Factor Assay (318/2016)

Terminated· Bayer logo

Bayer·N/A·NCT02995031·5 enrolled

Show 8 more trials

Sun Protection Factor Assay (319/2016)

Terminated· Bayer logo

Bayer·N/A·NCT02995044·5 enrolled

Sun Protection Factor Assay (SPF Assay 204/2016)

Completed· Bayer logo

Bayer·N/A·NCT02936544·11 enrolled

Sun Protection Factor Assay (338/2016)

Completed· Bayer logo

Bayer·N/A·NCT02995109·10 enrolled

Sun Protection Factor Assay (SPF Assay 207/2016)

Completed· Bayer logo

Bayer·N/A·NCT02936583·6 enrolled

Sun Protection Factor Assay (SPF Assay 205/2016)

Completed· Bayer logo

Bayer·N/A·NCT02936557·11 enrolled

Sun Protection Factor Assay (SPF Assay 206/2016)

Completed· Bayer logo

Bayer·N/A·NCT02936570·5 enrolled

Sun Protection Factor Assay (344/2016)

Completed· Bayer logo

Bayer·N/A·NCT02995161·10 enrolled

Sun Protection Factor Assay (343/2016)

Completed· Bayer logo

Bayer·N/A·NCT02995148·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 12 trial records for BAY987521. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — BAY987521 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for BAY987521. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bayer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Bayer

BAY987521

Status by Indication[3][1]

Trials by Indication[1]

Irritation1 trial

Unspecified11 trials

References

Drug Info

Quick Facts

Related News